Sustainable synthesis of luminescent CdTe quantum dots coated with modified silica mesoporous nanoparticles

The synthesis and full characterization of a family of sustainable luminescent nanoparticles, CdTeQDs@MNs, made of quantum dots coated by modified mesoporous silica nanoparticles is reported. The presence of the luminescent QDs allows the imaging of the nanoparticles during cell internalization, as...

Descripción completa

Detalles Bibliográficos
Autores: Oliveira, Elisabete|||0000-0002-8339-4820, Santos, Hugo M.|||0000-0002-6032-8679, Jorge, Susana|||0000-0003-4850-2387, Rodríguez-González, Benito, Novio, Fernando|||0000-0002-1517-3612, Lorenzo Rivera, Julia|||0000-0001-5659-6008, Ruiz-Molina, Daniel|||0000-0002-6844-8421, Capelo-Martínez, José Luis|||0000-0001-6276-8507, Lodeiro, Carlos|||0000-0001-5582-5446
Tipo de recurso: artículo
Fecha de publicación:2019
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:218075
Acceso en línea:https://ddd.uab.cat/record/218075
https://dx.doi.org/urn:doi:10.1016/j.dyepig.2018.09.047
Access Level:acceso abierto
Palabra clave:Luminescence
Quantum dots
Mesoporous silica nanoparticles
Doxorubicin
Proteins
Nanoproteomics
Descripción
Sumario:The synthesis and full characterization of a family of sustainable luminescent nanoparticles, CdTeQDs@MNs, made of quantum dots coated by modified mesoporous silica nanoparticles is reported. The presence of the luminescent QDs allows the imaging of the nanoparticles during cell internalization, as well as the visualization of selective release of doxorubicin inside the cell (via pH stimuli). The modified mesoporous silica nanoparticles lead to pore size improvement allowing better encapsulation and controlled release, of different active principles studied such as, small molecules (rhodamine B), drugs (doxorubicin), and isolated proteins such as bovine serum albumin, lysozyme, carbonic anhydrase, ovalbumin, α-lactalbumin, hemoglobin, myoglobin and cytochrome C. Finally, and as a proof-of-concept the efficacy of these novel platforms was demonstrated through the successful extraction and recognition of proteins in raw serum of osteoarthritis and prosthesis patients, without any previous protein depletion.